tiprankstipranks
Trending News
More News >
Regencell Bioscience Holdings Ltd. (RGC)
:RGC
US Market
Advertisement

Regencell Bioscience (RGC) Price & Analysis

Compare
481 Followers

RGC Stock Chart & Stats


Financials

Ownership Overview

<0.01%<0.01%100.00%
Insiders
<0.01%
Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and Individual Investors

RGC FAQ

What was Regencell Bioscience Holdings Ltd.’s price range in the past 12 months?
Regencell Bioscience Holdings Ltd. lowest stock price was $0.09 and its highest was $83.60 in the past 12 months.
    What is Regencell Bioscience Holdings Ltd.’s market cap?
    Regencell Bioscience Holdings Ltd.’s market cap is $7.51B.
      When is Regencell Bioscience Holdings Ltd.’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Regencell Bioscience Holdings Ltd.’s earnings last quarter?
      Currently, no data Available
      Is Regencell Bioscience Holdings Ltd. overvalued?
      According to Wall Street analysts Regencell Bioscience Holdings Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Regencell Bioscience Holdings Ltd. pay dividends?
        Regencell Bioscience Holdings Ltd. pays a Quarterly dividend of $0.22 which represents an annual dividend yield of N/A. See more information on Regencell Bioscience Holdings Ltd. dividends here
          What is Regencell Bioscience Holdings Ltd.’s EPS estimate?
          Regencell Bioscience Holdings Ltd.’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Regencell Bioscience Holdings Ltd. have?
          Regencell Bioscience Holdings Ltd. has 494,488,920 shares outstanding.
            What happened to Regencell Bioscience Holdings Ltd.’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Regencell Bioscience Holdings Ltd.?
            Currently, no hedge funds are holding shares in RGC

            Company Description

            Regencell Bioscience Holdings Ltd.

            Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
            Similar Stocks
            Company
            Price & Change
            Follow
            Dr Reddy's Laboratories
            Viatris
            Perrigo Company
            Teva Pharmaceutical
            HUTCHMED
            Popular Stocks
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis